Zobrazeno 1 - 5
of 5
pro vyhledávání: '"V. I. Aleynov"'
Autor:
I. A. Goroshinskaya, E. M. Frantsiyants, V. I. Aleynov, L. A. Nemashkalova, N. D. Cheryarina, A. V. Shaposhnikov, E. A. Dzhenkova
Publikováno v:
Issledovaniâ i Praktika v Medicine, Vol 7, Iss 2, Pp 30-46 (2020)
Purpose of the study. A comparative analysis of the intensity of lipid peroxidation and the functioning of various units of the antioxidant system in the blood of patients with malignant pancreatic lesions and with chronic pancreatitis.Patients and M
Externí odkaz:
https://doaj.org/article/a71de8f8cf3a4383a304970ef8c66e58
Publikováno v:
Issledovaniâ i Praktika v Medicine, Vol 6, Iss 3, Pp 51-64 (2019)
Pancreatic cancer (PC) is a lethal malignant tumor characterized by a rapid progression, invasiveness and resistance to radiochemotherapy. The development of biomarkers for the early diagnosis of the disease is relevant. Angiogenesis has been identif
Externí odkaz:
https://doaj.org/article/94f8d9e861624b9fa25d91c24ceadcd7
Autor:
Elena A. Dzhenkova, Nikolay S. Samoylenko, Larisa Kozlova, Maksim N. Duritskiy, Andrey A. Maslov, Oleg I. Kit, Elena M. Frantsiyants, Yuriy A. Gevorkyan, V. I. Aleynov
Publikováno v:
Journal of Clinical Oncology. 37:e15529-e15529
e15529 Background: The serine protease urokinase plasminogen activator (uPA) plays an important role in growth and invasion of malignant tumors. The purpose of the study was a comparative analysis of uPA activity (uPA-act) and its antigen (uPA-Ag) co
Autor:
Sergey I. Poluektov, Anton G. Milakin, Sergey V. Tumanyan, Yuriy A. Gevorkyan, Nikolay S. Samoylenko, Maksim N. Duritskiy, Natalya V. Soldatkina, V. I. Aleynov, Oleg I. Kit, Elena M. Frantsiyants, Larisa Kozlova
Publikováno v:
Journal of Clinical Oncology. 37:e15533-e15533
e15533 Background: Plasminogen regulator system is considered to be involved in migration, invasion and proliferation of malignant cells. The role of tissue plasminogen activator (tPA) and PAI-1 in cancer is still discussed. Our purpose was to study
Autor:
V. I. Aleynov, Irina V. Kaplieva, Maksim N. Duritskiy, Nikolay S. Samoylenko, Irina S. Tishchenko, Yuriy A. Gevorkyan, Oleg I. Kit, Elena M. Frantsiyants, Natalya V. Soldatkina, Valeria A. Bandovkina
Publikováno v:
Journal of Clinical Oncology. 37:e15527-e15527
e15527 Background: The primary tumor and associated but distinct from it premetastatic niches include a number of important participants: immune cells, stromal cells, extracellular matrix and associated effectors, in particular hormone receptors. Cro